Abstract
Background: Several trials support the transradial route of percutaneous coronary intervention (PCI) since it reduces accesssite vascular complications and bleeding. Objectives: To examine the effects of transradial interventions (TRI) on clinical outcomes in a ‘real-world’ cohort of patients undergoing PCI. Methods: We analyzed 4873 consecutive patients who underwent PCI at a tertiary center and identified 373 patients who underwent TRI. Patients (radial vs. femoral) were compared using a propensity score analysis to best match between groups. Outcome parameters included total mortality, myocardial infarction (MI), repeat target vessel revascularization (TVR) rates, length of hospitalization and ΔHt/Hb/creatinine values during hospitalization. These were evaluated at 6 months and 1 to 3 years after PCI. Results: The rates of major adverse cardiovascular event (MACE) and its constituents were similar in the transradial vs. transfemoral groups at all time intervals: 6.7% vs. 5.5% at 6 months, 10.3% vs. 10% at 1 year, 15.7% vs. 15% at 2 years, 15.7% vs. 16% at 3 years, respectively (P = 0.6). The length of hospitalization was shorter in the TRI group (2.87 days ± 2.04 vs. 3.3 days ± 3.12, P = 0.023). We did not find significant differences between the groups in the mean ΔHt/Hb/creatinine values during the hospitalization course. Conclusions: In a real-world setting of PCI, the TRI route of PCI is as safe and efficient as the femoral approach. TRI is associated with shorter duration of hospitalization.
Original language | English |
---|---|
Pages (from-to) | 360-364 |
Number of pages | 5 |
Journal | Israel Medical Association Journal |
Volume | 17 |
Issue number | 6 |
State | Published - 1 Jun 2015 |
Externally published | Yes |
Keywords
- Major adverse cardiovascular events (MACE)
- Percutaneous coronary intervention (PCI)
- Trans-radial intervention (TRI)
- Transfemoral intervention (TFI)
ASJC Scopus subject areas
- General Medicine